Company intelligence / Profile preview

Portal Biotechnologies, Inc.

(Cambridge/Kendall Sq.)*, Massachusetts, USAportalbiotech.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Portal has developed a next-generation mechanical intracellular delivery platform enabling efficient transfer of various biomolecules—including RNA, proteins, peptides, and gene-editing complexes—into a wide array of cell types. The technology underpins partnerships with major pharma/biotech companies and academic centers for both research use and integration into cell therapy workflows. Early access/beta programs are ongoing with over 50 partners globally. No direct clinical trial results reported as the company provides enabling technologies rather than developing its own therapeutics at this time.

Modalities: RNA (siRNA, mRNA)Gene editing (CRISPR RNP complexes)Polypeptides/proteins
Industry: Non-Drug Biotech

Partnerships

Multiple large pharmaceutical/biotechnology companiesProminent academic institutionsBayer Co.Lab memberRoche Accelerator affiliate

Beyond the preview

Go deeper on Portal Biotechnologies, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Portal Biotechnologies, Inc..

Explore the full profile